@nuvalent Nuvalent

Nuvalent posts on X about $nuvl, ceo, health care, we are the most. They currently have [---] followers and [--] posts still getting attention that total [---] engagements in the last [--] hours.

Engagements: [---] #

• [--] Week [---] -8.50%
• [--] Month [---] -36%
• [--] Months [------] +243%
• [--] Year [------] +601%

Mentions: [--] #

• [--] Months [--] -40%
• [--] Year [--] +114%

Followers: [---] #

• [--] Week [---] +0.51%
• [--] Month [---] +2.40%
• [--] Months [---] +8.90%
• [--] Year [---] +25%

CreatorRank: [---------] #

Social Influence

Social category influence stocks 12.2% finance 4.88% countries 2.44% financial services 2.44%

Social topic influence $nuvl #2, ceo 7.32%, health care 4.88%, we are 4.88%, hope 4.88%, community 4.88%, 30 2.44%, cfo 2.44%, alex 2.44%, science 2.44%

Top accounts mentioned or mentioned by @stifel @iaslc @lungevity @biotechch @morganstanley @guggenheimptnrss @mctaacr @alkpositiveinc @ubs @caringfchildren @thewrp4lc

Top assets mentioned Nuvalent, Inc. (NUVL) Morgan Stanley (MS)

Top Social Posts

Top posts by engagements in the last [--] hours

"Nuvalent CEO James Porter and CFO Alex Balcom MBA CPA are back in NYC next week for Piper Sandlers 37th Annual Healthcare Conference. A recording of the webcast will be available on our website for [--] days. $NUVL #biotech #oncology https://investors.nuvalent.com/2025-11-26-Nuvalent-to-Participate-in-the-Piper-Sandler-37th-Annual-Healthcare-Conference https://investors.nuvalent.com/2025-11-26-Nuvalent-to-Participate-in-the-Piper-Sandler-37th-Annual-Healthcare-Conference"
X Link 2025-11-26T11:35Z [---] followers, [---] engagements

"This morning we reported our Q3 [----] financial results alongside recent pipeline progress and anticipated [----] milestones. Read more: $NUVL https://investors.nuvalent.com/2025-10-30-Nuvalent-Highlights-Recent-Pipeline-Progress-Reiterates-Key-Anticipated-Milestones-and-Reports-Third-Quarter-2025-Financial-Results https://investors.nuvalent.com/2025-10-30-Nuvalent-Highlights-Recent-Pipeline-Progress-Reiterates-Key-Anticipated-Milestones-and-Reports-Third-Quarter-2025-Financial-Results"
X Link 2025-10-30T10:33Z [---] followers, [---] engagements

"Join CEO James Porter and CFO Alex Balcom MBA CPA in a fireside chat at the upcoming Guggenheim Securities Emerging Outlook: Biotech Summit on February [--] at 1:30pm EST. A recording of the webcast will be available on our website for [--] days. $NUVL https://investors.nuvalent.com/2026-02-05-Nuvalent-to-Participate-in-the-Guggenheim-Emerging-Outlook-Biotech-Summit-2026 https://investors.nuvalent.com/2026-02-05-Nuvalent-to-Participate-in-the-Guggenheim-Emerging-Outlook-Biotech-Summit-2026"
X Link 2026-02-05T11:38Z [---] followers, [---] engagements

"The breakthroughs of today are built on the courage of yesterday. This International Day of Women & Girls in Science were honored to recognize the pioneers who transformed our industry and the incredible women across Nuvalent who continue to push science forward. #WomenInSTEM"
X Link 2026-02-11T18:56Z [---] followers, [---] engagements

"📣 Were excited to announce the Phase [--] portion of our ARROS-1 clinical trial of NVL-520 for patients with ROS1-positive #NSCLC & other solid tumors is open & enrolling following alignment with the FDA on a recommended Phase [--] dose. Learn more:"
X Link 2023-09-05T13:00Z [---] followers, [---] engagements

"Congratulations toHenryPelish our Senior Vice President Drug Discovery for being honored in this years #PharmaVoice100 list as a Trailblazer. This award highlights top leaders in biotech who guide innovation in the field. Read"
X Link 2023-09-22T13:39Z [---] followers, [--] engagements

"Catch our CEO James Porter PhD as he joins the @BiotechCH to talk chemistry de-risking TKIs and our recent successful financing following positive preliminary Ph [--] data at the 35th AACR-NCI-EORTC Symposium. Tune in below"
X Link 2023-10-26T18:38Z [---] followers, [---] engagements

"#NuCrewOutings in New York😎 What a great opportunity to celebrate everything weve achieved as a team cheers to the amazing journey ahead $NUVL #biotech #oncology"
X Link 2024-07-05T14:24Z [---] followers, [---] engagements

"We are delighted to announce Henry Pelishs promotion to Chief Scientific Officer reflecting his significant contributions at Nuvalent Read more here: #biotech #oncology $NUVL #leadership https://investors.nuvalent.com/2024-07-11-Nuvalent-Announces-Promotion-of-Henry-Pelish-Ph-D-to-Chief-Scientific-Officer https://investors.nuvalent.com/2024-07-11-Nuvalent-Announces-Promotion-of-Henry-Pelish-Ph-D-to-Chief-Scientific-Officer"
X Link 2024-07-11T13:00Z [---] followers, [---] engagements

"🗓 Join our CEO James Porter & CFO Alex Balcom at the @MorganStanley Annual Healthcare Conference on Wednesday September 5th [----] at 1:05 p.m. ET in New York City Webcast recordings will be available on our website for [--] days. $NUVL #biotech #oncology https://investors.nuvalent.com/2024-08-29-Nuvalent-to-Participate-in-the-Morgan-Stanley-22nd-Annual-Global-Healthcare-Conference https://investors.nuvalent.com/2024-08-29-Nuvalent-to-Participate-in-the-Morgan-Stanley-22nd-Annual-Global-Healthcare-Conference"
X Link 2024-08-29T13:00Z [---] followers, [---] engagements

"HOT JOB ALERT 🚨 Director IT Business Partner Commercial & Medical Affairs 🚨 Interested in joining the #NuCrew Learn more about this role and other new opportunities here: #NuTalent #hiring #biotech https://nuvalent.com/jobs/gh_jid=5356912004 https://nuvalent.com/jobs/gh_jid=5356912004"
X Link 2024-11-01T14:56Z [---] followers, [---] engagements

"$NUVL: Q3 [----] ✅Achieved all [----] milestones outlined in OnTarget [----] 🔬Planned initiation of the ALKAZAR Ph [--] trial of NVL-655 in 1H [----] 🤝Welcomed Alice Shaw MD PhD to our SAB Upsized public offering expected to extend operating runway into [----] https://investors.nuvalent.com/2024-11-12-Nuvalent-Highlights-Corporate-and-Pipeline-Achievements-Reiterates-Key-Anticipated-Milestones-and-Reports-Third-Quarter-2024-Financial-Results"
X Link 2024-11-12T14:04Z [---] followers, [---] engagements

"Join our CEO & CFO this month at @GuggenheimPtnrs's Inaugural Healthcare Innovation Conference in Boston and the @Stifel [----] Healthcare Conference in NYC. Webcast recordings will be available on our website for [--] days. $NUVL #biotech #oncology https://investors.nuvalent.com/2024-11-12-Nuvalent-Highlights-Corporate-and-Pipeline-Achievements-Reiterates-Key-Anticipated-Milestones-and-Reports-Third-Quarter-2024-Financial-Results"
X Link 2024-11-12T19:39Z [---] followers, [---] engagements

"HOT JOB ALERT 🚨 Senior Manager Clinical Operations🚨 Interested in joining the #NuCrew Learn more about this role and other new opportunities here: #NuTalent #hiring #biotech https://nuvalent.com/jobs/gh_jid=5340347004 https://nuvalent.com/jobs/gh_jid=5340347004"
X Link 2025-01-21T14:00Z [---] followers, [---] engagements

"Join Nuvalent CEO Jim Porter and CFO Alex Balcom at TD Cowen's Annual Health Care Conference in Boston Leerink Partners' Global Biopharma Conference & Barclays Global Healthcare Conference in Miami. Webcast recordings available on our website for [--] days. https://investors.nuvalent.com/2025-02-28-Nuvalent-to-Participate-in-Upcoming-March-Investor-Conferences https://investors.nuvalent.com/2025-02-28-Nuvalent-to-Participate-in-Upcoming-March-Investor-Conferences"
X Link 2025-02-28T14:04Z [---] followers, [---] engagements

"Join Nuvalent CEO James Porter and CFO Alex Balcom this month at @Stifel 's [----] Virtual Targeted Oncology Forum. Recordings of the webcast will be available on our website for [--] days. $NUVL #biotech #oncology https://investors.nuvalent.com/2025-04-01-Nuvalent-to-Participate-in-the-Stifel-2025-Virtual-Targeted-Oncology-Forum https://investors.nuvalent.com/2025-04-01-Nuvalent-to-Participate-in-the-Stifel-2025-Virtual-Targeted-Oncology-Forum"
X Link 2025-04-01T12:57Z [---] followers, [---] engagements

"Our team is at #AACR2025 Be sure to visit our poster on #neladalkib (NVL-655) which includes new data that reinforce its differentiated preclinical profile during this mornings session. Learn more: #Nuvalent #biotech #preclinicaldata https://nuvalent.com/wp-content/uploads/2025/04/tangpeerachaikul-aacr-2025-neladalkib-preclinical-mutagenesis-screen.pdf https://nuvalent.com/wp-content/uploads/2025/04/tangpeerachaikul-aacr-2025-neladalkib-preclinical-mutagenesis-screen.pdf"
X Link 2025-04-28T13:00Z [---] followers, [---] engagements

"Our latest manuscript has been published in @MCT_AACR highlighting preclinical data supporting the molecular design of #zidesamtinib our novel and selective ROS1 & providing key structural insights into how the ROS1 G2032R mutation impacts TKI binding. https://aacrjournals.org/mct/article/doi/10.1158/1535-7163.MCT-25-0025/762062/Zidesamtinib-Selective-Targeting-of-Diverse-ROS1 https://aacrjournals.org/mct/article/doi/10.1158/1535-7163.MCT-25-0025/762062/Zidesamtinib-Selective-Targeting-of-Diverse-ROS1"
X Link 2025-04-29T17:13Z [---] followers, [---] engagements

"This morning we reported our Q1 [----] financial results alongside recent business & pipeline progress. Highlights include continued progress toward planned milestones & key internal promotions that strengthen our leadershipteam. Read more: $NUVL #biotech https://investors.nuvalent.com/2025-05-08-Nuvalent-Outlines-Recent-Pipeline-and-Business-Progress-Reiterates-Key-Anticipated-Milestones-and-Reports-First-Quarter-2025-Financial-Results"
X Link 2025-05-08T13:05Z [---] followers, [---] engagements

"Were heading to San Diego as a proud sponsor of this years @ALKPositiveinc Summit We look forward to connecting with patients caregivers and healthcare experts as we explore the latest in #ALK+ NSCLC research and cancer care. Register: #ALKSummit25 https://secure.qgiv.com/for/alksummit2025/event/2025alksummit/ https://secure.qgiv.com/for/alksummit2025/event/2025alksummit/"
X Link 2025-07-18T13:00Z [---] followers, [---] engagements

"🔗Connect with us atthis week's @IASLC Targeted Therapies of Lung Cancer Meeting in Huntington Beach CA"
X Link 2025-02-18T14:35Z [---] followers, [----] engagements

"This morning we reported our Q2 [----] financial results alongside recent pipeline & business achievements and anticipated milestones. Read more: $NUVL https://investors.nuvalent.com/2025-08-07-Nuvalent-Highlights-Pipeline-and-Business-Achievements-Reiterates-Key-Anticipated-Milestones-and-Reports-Second-Quarter-2025-Financial-Results https://investors.nuvalent.com/2025-08-07-Nuvalent-Highlights-Pipeline-and-Business-Achievements-Reiterates-Key-Anticipated-Milestones-and-Reports-Second-Quarter-2025-Financial-Results"
X Link 2025-08-07T10:35Z [---] followers, [----] engagements

"Our CEO James Porter and CFO Alex Balcom MBA CPA are back in NYC next week for Cantor's Global Healthcare Conference [----]. A recording of the webcast will be available on our website for [--] days. $NUVL #oncology #biotech https://bit.ly/3QETMoz https://bit.ly/3QETMoz"
X Link 2025-08-28T10:38Z [---] followers, [---] engagements

"Join Nuvalent CEO James Porter and CFO Alex Balcom next week at the @UBS [----] Virtual Oncology Day. Recordings of the webcast will be available on our website for [--] days. $NUVL #biotech #oncology https://investors.nuvalent.com/2025-09-24-Nuvalent-to-Participate-in-the-UBS-2025-Virtual-Oncology-Day https://investors.nuvalent.com/2025-09-24-Nuvalent-to-Participate-in-the-UBS-2025-Virtual-Oncology-Day"
X Link 2025-09-24T10:38Z [---] followers, [---] engagements

"Interested in joining a dynamic company that aims to develop precision medicines for oncology targets We're seeking an Associate Director Global Regulatory Affairs to help oversee global development strategy & regulatory operations. Learn more: #hiring https://bit.ly/3N0Clx6 https://bit.ly/3N0Clx6"
X Link 2023-06-12T13:00Z [---] followers, [---] engagements

"A first look beyond NSCLC ✨ We are proud to present preliminary clinical data for neladalkib an investigational ALK-selective inhibitor in patients with advanced #ALK- positive solid tumors outside of NSCLC at #ESMO25. https://investors.nuvalent.com/2025-10-18-Nuvalent-Presents-Preliminary-Data-for-Neladalkib-in-Advanced-ALK-positive-Solid-Tumors-Beyond-NSCLC-at-ESMO-2025 https://investors.nuvalent.com/2025-10-18-Nuvalent-Presents-Preliminary-Data-for-Neladalkib-in-Advanced-ALK-positive-Solid-Tumors-Beyond-NSCLC-at-ESMO-2025"
X Link 2025-10-18T10:05Z [---] followers, [----] engagements

"When Kirk first heard ALK+ NSCLC he didnt know where to start. Now he shares his story to inspire others to ask questions seek info and explore every option. Knowledge brings hope. Learn more: #LungCancerAwarenessMonth #ALKPositive #TheROS1ders http://elevatelungcancercare.com http://elevatelungcancercare.com"
X Link 2025-11-03T14:00Z [---] followers, [---] engagements

"Join us at the [----] @IASLC ASCO North America Lung Cancer Conference where we'll present the first look at patient-reported outcomes from the Phase [--] portion of our ARROS-1 Phase 1/2 clinical trial of investigational candidate zidesamtinib. https://investors.nuvalent.com/2025-11-04-Nuvalent-to-Present-Patient-Reported-Outcomes-Data-from-ARROS-1-Trial-of-ROS1-Selective-Inhibitor-Zidesamtinib-at-2025-IASLC-ASCO-North-America-Conference-on-Lung-Cancer"
X Link 2025-11-04T22:44Z [---] followers, [---] engagements

"📅 Today is National Lung Cancer Screening Day #LungCancer isnt just a smokers disease and stories like Jims show anyone can be affected. Early screening & genomic testing save lives 💙 Learn more: #LungCancerAwarenessMonth https://www.lungcancerscreeningday.org/ https://www.lungcancerscreeningday.org/"
X Link 2025-11-08T13:59Z [---] followers, [---] engagements

"⚡TUNE IN ON MONDAY: Topline pivotal data for TKI pre-treated patients with advanced ALK+ NSCLC from our ALKOVE-1 clinical trial of investigational candidate neladalkib are coming. Join our live webcast & conference call on November [--] [----] at 8:00am ET. https://investors.nuvalent.com/2025-11-14-Nuvalent-Announces-Timing-of-Topline-Pivotal-Data-for-TKI-Pre-treated-Patients-with-Advanced-ALK-positive-NSCLC-from-ALKOVE-1-Clinical-Trial-of-Neladalkib"
X Link 2025-11-14T21:05Z [---] followers, [---] engagements

"Today we shared positive topline pivotal results for our investigational candidate neladalkib in TKI pre-treated patients with advanced ALK+ NSCLC from our global ALKOVE-1 Phase 1/2 clinical trial. Learn more here: https://investors.nuvalent.com/2025-11-17-Nuvalent-Announces-Positive-Topline-Pivotal-Data-from-ALKOVE-1-Clinical-Trial-of-Neladalkib-for-TKI-Pre-treated-Patients-with-Advanced-ALK-positive-NSCLC"
X Link 2025-11-17T11:33Z [---] followers, [----] engagements

"For the 5th holiday season in a row the #NuCrew proudly supported the @caringfchildren annual gift drive. This year we are honored to sponsor [--] children from [--] local families facing #cancer and other serious diseases. https://frankccc.com/ https://frankccc.com/"
X Link 2025-12-18T14:00Z [---] followers, [---] engagements

"We look forward to seeing you at the 44th Annual J.P. Morgan Healthcare Conference Our CEO James Porter will present on January [--] at 9:00 AM PST. A recording of the presentation will be available on the conference website for [--] days. #JPM26 #Oncology https://investors.nuvalent.com/2025-12-22-Nuvalent-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference https://investors.nuvalent.com/2025-12-22-Nuvalent-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference"
X Link 2025-12-22T11:33Z [---] followers, [---] engagements

"Today we announced pipeline progress and outlined key anticipated milestones for [----] towards our first potential U.S. commercial launch under our OnTarget [----] operating plan. Read more: #NSCLC https://investors.nuvalent.com/2026-01-12-Nuvalent-Announces-OnTarget-2026-Operating-Plan-Progress-and-Outlines-Key-Anticipated-2026-Milestones https://investors.nuvalent.com/2026-01-12-Nuvalent-Announces-OnTarget-2026-Operating-Plan-Progress-and-Outlines-Key-Anticipated-2026-Milestones"
X Link 2026-01-12T11:33Z [---] followers, [---] engagements

"Behind every cancer diagnosis is a unique human story. At Nuvalent these stories inspire us and drive our efforts to develop and deliver #PreciselyTargetedTherapies for people living with #cancer with empathy and intention. #UnitedByUnique #WorldCancerDay"
X Link 2026-02-04T14:00Z [---] followers, [---] engagements

"November is #LungCancerAwarenessMonth. Join us along with @LUNGevity and the entire #LungCancer community to take action and spread awareness this month and year-round. http://lungevity.org/LCAM http://lungevity.org/LCAM"
X Link 2025-11-01T16:34Z [---] followers, [---] engagements

"💙 This #LungCancerAwarenessMonth were proud to support @LUNGevity in their efforts to transform #LungCancer care. Looking forward to tonights 13th Annual Celebration in NYC & this weekends walk with the community at #BreatheDeepTOGETHER in Somerville MA 🌟 #BreatheDeep25"
X Link 2025-11-06T14:00Z [---] followers, [---] engagements

"Did you know today is #NationalBiomarkerTestingDay Biomarker testing saves extends & improves lives. By testing for gene mutations people living with lung cancer are exposed to more treatment options that best treat their lung cancer. Learn more: https://tinyurl.com/5y44ucsn Today is #NationalBiomarkerTestingDay #BiomarkerTesting helps save extend & improve lives by identifying #GeneMutations & unlocking personalized #LungCancer treatment options. Learn more: https://t.co/hogBBe6ULW https://t.co/OUuhUEKfrN https://tinyurl.com/5y44ucsn Today is #NationalBiomarkerTestingDay #BiomarkerTesting"
X Link 2025-11-13T18:37Z [---] followers, [---] engagements

"We're excited to share that the FDA has accepted for filing our NDA for zidesamtinib our investigational ROS1-selective inhibitor for the treatment of adult patients with locally advanced or metastatic ROS1+ NSCLC who received at least [--] prior ROS1 TKI. https://investors.nuvalent.com/2025-11-19-Nuvalent-Announces-FDA-Acceptance-of-New-Drug-Application-for-Zidesamtinib-for-the-Treatment-of-TKI-Pre-treated-Patients-with-Advanced-ROS1-positive-NSCLC"
X Link 2025-11-20T14:00Z [---] followers, [---] engagements

"Together with Heidi co-founder of @TheWRP4LC the #NuCrew joined in making White Ribbons with messages of hope to remind patients with #LungCancer that theyre not alone. 🤍 #TheWhiteRibbonProject"
X Link 2025-12-08T14:00Z [---] followers, [---] engagements

"Welcome Ron Squarer to our Board of Directors Ron's success in evolving R&D organizations to fully integrated businesses strengthens our Board as we advance toward the potential approval and launch of our first product in https://investors.nuvalent.com/2025-12-10-Nuvalent-Appoints-Ron-Squarer-to-Board-of-Directors https://investors.nuvalent.com/2025-12-10-Nuvalent-Appoints-Ron-Squarer-to-Board-of-Directors"
X Link 2025-12-10T21:05Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing